PRESS RELEASE published on 01/17/2024 at 08:00, 1 year 11 months ago Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Published on 12/22/2025 at 08:05, 1 hour 46 minutes ago Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development
Published on 12/20/2025 at 00:30, 2 days 9 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 11 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 15 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 19 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/22/2025 at 09:30, 21 minutes ago Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability
Published on 12/22/2025 at 09:22, 29 minutes ago Heirs Energies Agrees $750m Afreximbank Financing to Drive Long-Term Growth
Published on 12/22/2025 at 09:22, 29 minutes ago Heirs Energies conclut un accord de financement de 750 millions USD avec Afreximbank pour stimuler sa croissance à long terme
Published on 12/22/2025 at 09:00, 50 minutes ago Original-Research: Cantourage Group SE (von NuWays AG): BUY
Published on 12/22/2025 at 09:18, 32 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025
Published on 12/22/2025 at 09:18, 32 minutes ago GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 11/12/2025
Published on 12/19/2025 at 21:57, 2 days 11 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 3 days 1 hour ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 3 days 1 hour ago Réduction du capital par voie d’annulation d’actions propres